2020 / 02

Next Paper
DOI: 10.24075/brsmu.2020.025

OPINION

On the unpredictability of outcomes of immunotherapy and preventive immunization against COVID-19

Chebotar IV, Shagin DA
About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Igor V. Chebotar
Ostrovityanova, 1, Moscow, 117997; ur.xednay@nnrazin

About paper

Author contribution: the authors equally contributed to the manuscript

Received: 2020-04-21 Accepted: 2020-04-28 Published online: 2020-04-30
|
  1. Vremennye metodicheskie rekomendatsii Ministerstva zdravookhraneniya Rossiyskoy Federatsii «Lekarstvennaya terapiya ostrykh respiratornykh virusnykh infektsiy (ORVI) v ambulatornoy praktike v period epidemii COVID-19». Versiya 5 (08.04.2020). Available from: https://static-1.rosminzdrav.ru/system/attachments/ attaches/000/049/986/original/09042020_%D0%9C%D0%A0_ COVID-19_v5.pdf.
  2. Cao YC, Deng QX, Dai SX. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of the evidence. Travel Med Infect Dis. 2020; 2: 101647. DOI: 10.1016/j. tmaid.2020.101647.
  3. Centers for Disease Control and Prevention. Information for Clinicians on Investigational Therapeutics for Patients with COVID-19. Available from: https://www.cdc.gov/coronavirus/2019-ncov.
  4. Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD Jr, Coccia JA, et al. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis. 2005; 191 (4): 507–14. DOI: 10.1086/427242.
  5. Chen Z, Bao L, Chen C, Zou T, Xue Y, Li F, et al. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset. J Infect Dis. 2017; 215 (12): 1807–15. DOI: 10.1093/ infdis/jix209.
  6. Kleine-Weber H, Elzayat MT, Wang L, Graham BS, Müller MA, Drosten C, et al. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization. J Virol. 2019; 93 (2): pii: e01381-18. DOI: 10.1128/JVI.01381-18.
  7. Yang ZY, Werner HC, Kong WP, Leung K, Traggiai E, Lanzavecchia A, et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci USA. 2005; 102 (3): 797–01. DOI: 10.1073/pnas.0409065102.
  8. Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, et al. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J Virol. 2020; 94 (5): pii: e02015-19. DOI: 10.1128/ JVI.02015-19 .
  9. Yip MS, Leung HL, Li PH, Cheung CY, Dutry I, Li D, et al. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. Hong Kong Med J. 2016; 22 (3 Suppl 4): 25–31.